Pharmacogenetic testing is available through several channels: your doctor’s office, hospital-based genetics clinics, some independent pharmacies, and direct-to-consumer companies like 23andMe. The right option depends on why you want testing, what medications you’re taking, and whether you need results your doctor can act on clinically.
Through Your Doctor or Specialist
The most common way to get pharmacogenetic testing is through a healthcare provider who orders it based on your current or planned medications. Your doctor collects a sample, either blood from a vein, saliva in a tube, or a quick swab of the inside of your cheek, and sends it to a clinical laboratory for analysis. Results typically come back to your provider, who reviews them and adjusts your treatment if needed.
This route matters most when you’re starting a medication where genetic variants could cause a serious reaction. The FDA maintains specific warnings for certain drugs. For example, the HIV drug abacavir should not be used in patients who carry a particular genetic variant (HLA-B*57:01), and the seizure medication carbamazepine requires caution in people with a different variant. In cases like these, your prescribing doctor will often order targeted testing before writing the prescription. Medicare covers pharmacogenetic testing when there’s documented medical necessity, meaning your provider must record which drugs are being considered and why the test is needed for clinical decision-making. Private insurers vary, but generally follow similar logic: if a specific medication is on the table and testing would change the prescribing decision, coverage is more likely.
Hospital and Academic Medical Center Clinics
A growing number of academic medical centers run dedicated pharmacogenomics clinics. These programs pair genetic medicine specialists with pharmacists to give you a more comprehensive evaluation. The University of Nebraska Medical Center, for instance, operates a pharmacogenetics clinic through its Munroe-Meyer Institute where a team first assesses whether testing could meaningfully affect your care, orders appropriate tests, and then brings you back for a follow-up visit to walk through the results.
Similar programs exist at major medical centers across the country, including institutions like St. Jude Children’s Research Hospital, the Mayo Clinic, and Vanderbilt University Medical Center. These clinics are especially useful if you take multiple medications, have a history of unexpected drug reactions, or have a complex condition where getting the right drug at the right dose matters a great deal. The NIH’s Genetic Testing Registry (available at ncbi.nlm.nih.gov/gtr) lets you search by gene name or condition to find laboratories that perform specific pharmacogenetic tests, which can help you and your doctor identify where to send samples.
Independent and Community Pharmacies
Some independent community pharmacies now offer pharmacogenetic testing either as a standalone service or as part of medication therapy management. In a North Carolina trial studying this model, pharmacists identified eligible patients, provided counseling before and after testing, collected samples, shipped them to a lab, interpreted results, and communicated findings to the patient’s prescriber. This is a newer delivery model, and availability varies widely by location, but it’s worth asking your local independent pharmacy if they participate in any pharmacogenomics programs.
Chain pharmacies have been slower to roll out formal testing services, though they have infrastructure advantages like clinical decision support systems and patient education resources that could make the process smoother. The pharmacy route works well for people already managing several prescriptions who want a pharmacist’s perspective on how their genetics might affect their drug regimen.
Direct-to-Consumer Testing
23andMe is the most recognizable direct-to-consumer option. Their pharmacogenetic reports cover variants in several key genes that influence how your body processes medications, including CYP2C19, CYP2D6, CYP2C9, and others. You collect a saliva sample at home and mail it to their lab. The process is straightforward and doesn’t require a doctor’s order.
There’s an important limitation, though. The FDA has authorized 23andMe’s pharmacogenetic reports only as informational tools to support conversations with a healthcare provider. The FDA has not authorized any direct-to-consumer pharmacogenetic test that predicts whether you will respond to, or have adverse reactions from, a specific drug. The reports tell you which genetic variants you carry, but they are explicitly not meant to be used to start, stop, or change any medication on your own. Think of these results as a conversation starter with your doctor, not a prescription guide.
The clinical-grade tests ordered by your doctor are held to different analytical standards and often cover a broader range of variants for each gene. If you’re dealing with a real prescribing decision right now, a clinician-ordered test will carry more weight.
What Testing Covers
Most pharmacogenetic panels focus on enzymes your liver uses to break down drugs. The genes tested most frequently include CYP2D6 (which metabolizes roughly 25% of commonly prescribed drugs, including many antidepressants and pain medications), CYP2C19 (relevant to certain anti-clotting drugs and antidepressants), and CYP2C9 paired with VKORC1 (which together influence warfarin dosing). Other commonly tested genes affect how you process certain chemotherapy drugs, cholesterol-lowering statins, and immunosuppressants.
Your results will typically classify you as a normal, rapid, or poor metabolizer for each enzyme. A poor metabolizer breaks down a drug slowly, meaning standard doses could build up to toxic levels. A rapid or ultra-rapid metabolizer clears the drug too fast, so standard doses may not work. Knowing your metabolizer status helps your doctor choose the right drug and dose from the start, potentially avoiding weeks of trial and error.
Cost and Insurance Coverage
Out-of-pocket costs range widely. Direct-to-consumer kits from 23andMe include pharmacogenetic reports as part of their health service package, generally in the $200 to $300 range. Clinical tests ordered by a provider can cost anywhere from $250 to over $1,000 depending on how many genes are tested, though insurance often reduces that significantly when medical necessity is established.
Medicare covers pharmacogenetic testing under specific conditions. The performing lab must document which drugs are being considered by the ordering physician, and only one test per date of service is allowed. That test should be the one most likely to identify the relevant genetic variants for the drug or drugs in question, whether it’s a single gene test or a multigene panel. Any additional testing beyond that requires separate documentation of medical necessity in your medical record. If your insurer initially denies coverage, having your doctor document the specific clinical rationale, particularly when prescribing a drug with FDA pharmacogenetic labeling, strengthens an appeal.
How to Choose the Right Option
If you’re about to start a medication with known genetic considerations, ask your prescribing doctor to order testing. This gives you clinically actionable results, the best chance at insurance coverage, and a provider who can immediately use the information. If you’re broadly curious about how your body handles medications and want a starting point for future conversations, a direct-to-consumer test can provide useful baseline information at a predictable cost. And if you’re managing multiple medications and want help making sense of how they interact with your genetics, a pharmacogenomics clinic at an academic medical center offers the most thorough evaluation.
Whichever route you choose, the test itself is simple. A saliva sample or cheek swab takes under a minute. Blood draws are quick and routine. Results generally take one to four weeks depending on the lab, and once you have them, they’re valid for life since your DNA doesn’t change. A single test today can inform prescribing decisions for decades.